The Market's Mispricing This Miner
Cameco should benefit meaningfully from a recovery in uranium.
We think the market is mispricing narrow-moat uranium miner Cameco (CCJ). Uranium offers a rare growth opportunity in metals and mining. China’s structural slowdown portends the end of a decade-long boom for most commodities--but not for uranium.
Uranium prices fell each year from 2011 to 2017, owing to the supply glut caused by delayed Japanese reactor restarts. This situation shouldn’t last much longer, with prices beginning to recover in 2018. We expect global uranium demand to rise roughly 40% by 2025, a staggering amount for a commodity that saw next to zero demand growth in the past 10 years. We expect new reactor capacity to drive the strongest uranium demand growth in decades. A quadrupling of China’s reactor fleet headlines this growth. China’s modest nuclear reactor fleet uses little uranium today. That’s set to change in a major way. Beijing is pivoting to nuclear in order to reduce the country’s heavy reliance on coal. New reactors in India, South Korea, and Russia as well as restarts in Japan lend additional support.
Kristoffer Inton does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.